Literature DB >> 16396778

Prolymphocytoid transformation of follicular lymphoma with coexpression of CD5 and CD10.

Sean K Lau1, Lawrence M Weiss, Yibin Zhang, Qin Huang.   

Abstract

Histologic transformation of follicular lymphoma is usually to a diffuse large B-cell lymphoma. We present a rare example of a histologic transformation of follicular lymphoma manifested by prolymphocytoid morphology and an unusual immunophenotype characterized by coexpression of CD5 and CD10. The transformed prolymphocytoid lymphoma was positive for CD5 and CD10 antigens by both flow cytometry and immunohistochemistry. The case also expressed bcl-2 and bcl-6 proteins, and exhibited t(14;18), consistent with derivation from a pre-existing follicular lymphoma. Polymerase chain reaction analysis of the immunoglobulin kappa light chain genes derived from the follicular lymphoma and prolymphocytoid lymphoma showed identical rearranged bands, suggesting clonal identity of the two neoplasms. The basis for coexpression of CD5 and CD10 remains unclear. Because the preceding low-grade follicular lymphoma was positive only for CD10 and did not express CD5, CD5 expression appears to be an acquired phenomenon accompanying the process of histologic transformation in this particular case. Prolymphocytoid transformation, similar to other histologic forms of transformation of follicular lymphoma, appears to accompany clinical progression of disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16396778     DOI: 10.1080/10520290500305310

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  3 in total

1.  Establishment of CD5 and CD10 double-positive mature B-cell line, WILL1, showing complex 8q24 translocation involving 14q32 and 6q27.

Authors:  Shima Uneda; Minako Gotoh; Takashi Sonoki; Kazuhiro Nishida; Yasushi Nakamura; Miwa Kurimoto; Nobuyoshi Hanaoka; Hiroshi Matsuoka; Masafumi Taniwaki; Hideki Nakakuma
Journal:  Int J Hematol       Date:  2008-10-30       Impact factor: 2.490

2.  Follicular lymphoma suggested to transform into EBV-negative plasmablastic lymphoma.

Authors:  Toshiki Yamada; Takeshi Hara; Naoe Goto; Hitoshi Iwata; Hisashi Tsurumi
Journal:  Int J Hematol       Date:  2019-03-11       Impact factor: 2.490

3.  Aggressive CD5-positive B-cell lymphoma after remission of CD5-negative follicular lymphoma with distinct immunoglobulin heavy chain rearrangement and translocation.

Authors:  Takashi Sonoki; Sonoko Ishihara; Shima Uneda; Nobuyoshi Hanaoka; Miwa Kurimoto; Hiroshi Matsuoka; Hideki Nakakuma
Journal:  Int J Hematol       Date:  2008-08-30       Impact factor: 2.490

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.